<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141659597763750%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201902022%26RESULT%3d1%26SIGN%3dhEhnl4KuDYJjornPJr1nRjasgxM%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201902022&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201902022&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201902022&amp;v=MTc2NzMzenFxQnRHRnJDVVI3cWZadVptRnlqbVZMN0tQVFhNWmJHNEg5ak1yWTlIWm9RS0RIODR2UjRUNmo1NE8=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#38" data-title="&lt;b&gt;1 资料与方法&lt;/b&gt; "><b>1 资料与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#39" data-title="1.1 一般资料">1.1 一般资料</a></li>
                                                <li><a href="#41" data-title="1.2 治疗方法">1.2 治疗方法</a></li>
                                                <li><a href="#43" data-title="1.3 观察指标">1.3 观察指标</a></li>
                                                <li><a href="#46" data-title="1.4 统计学处理">1.4 统计学处理</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#49" data-title="&lt;b&gt;2 结 果&lt;/b&gt; "><b>2 结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#50" data-title="2.1 临床疗效">2.1 临床疗效</a></li>
                                                <li><a href="#52" data-title="2.2 两组血糖水平比较">2.2 两组血糖水平比较</a></li>
                                                <li><a href="#57" data-title="2.3 两组血脂水平比较">2.3 两组血脂水平比较</a></li>
                                                <li><a href="#59" data-title="2.4 两组凝血功能指标比较">2.4 两组凝血功能指标比较</a></li>
                                                <li><a href="#65" data-title="2.5 两组血流变指标比较">2.5 两组血流变指标比较</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#69" data-title="&lt;b&gt;3 讨 论&lt;/b&gt; "><b>3 讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#54" data-title="&lt;b&gt;表&lt;/b&gt;1 &lt;b&gt;两组临床疗效对比&lt;/b&gt; (n=56) "><b>表</b>1 <b>两组临床疗效对比</b> (n=56) </a></li>
                                                <li><a href="#55" data-title="&lt;b&gt;表&lt;/b&gt;2 &lt;b&gt;治疗前后两组血糖水平对比&lt;/b&gt;&lt;mathml id=&quot;56&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt; (&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;X&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo&gt;, &lt;/mo&gt;&lt;mtext&gt;n&lt;/mtext&gt;&lt;mo&gt;=&lt;/mo&gt;&lt;mn&gt;5&lt;/mn&gt;&lt;mn&gt;6&lt;/mn&gt;&lt;mo stretchy=&quot;false&quot;&gt;) &lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>2 <b>治疗前后两组血糖水平对比</b><mathml id="56"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>X</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>, </mo><mtext>n</mtext><mo>=</mo><mn>5</mn><mn>6</mn><mo stretchy="false">) </mo></mrow></math></mathml></a></li>
                                                <li><a href="#61" data-title="&lt;b&gt;表&lt;/b&gt;3 &lt;b&gt;治疗前后两组血脂指标对比&lt;/b&gt;&lt;mathml id=&quot;62&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt; (&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;X&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo&gt;, &lt;/mo&gt;&lt;mtext&gt;n&lt;/mtext&gt;&lt;mo&gt;=&lt;/mo&gt;&lt;mn&gt;5&lt;/mn&gt;&lt;mn&gt;6&lt;/mn&gt;&lt;mo stretchy=&quot;false&quot;&gt;) &lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>3 <b>治疗前后两组血脂指标对比</b><mathml id="62"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>X</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>, </mo><mtext>n</mtext><mo>=</mo><mn>5</mn><mn>6</mn><mo stretchy="false">) </mo></mrow></math></mathml></a></li>
                                                <li><a href="#63" data-title="&lt;b&gt;表&lt;/b&gt;4 &lt;b&gt;治疗前后两组凝血功能指标对比&lt;/b&gt;&lt;mathml id=&quot;64&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt; (&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;X&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo&gt;, &lt;/mo&gt;&lt;mtext&gt;n&lt;/mtext&gt;&lt;mo&gt;=&lt;/mo&gt;&lt;mn&gt;5&lt;/mn&gt;&lt;mn&gt;6&lt;/mn&gt;&lt;mo stretchy=&quot;false&quot;&gt;) &lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>4 <b>治疗前后两组凝血功能指标对比</b><mathml id="64"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>X</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>, </mo><mtext>n</mtext><mo>=</mo><mn>5</mn><mn>6</mn><mo stretchy="false">) </mo></mrow></math></mathml></a></li>
                                                <li><a href="#67" data-title="&lt;b&gt;表&lt;/b&gt;5 &lt;b&gt;治疗前后两组血流变指标对比&lt;/b&gt;&lt;mathml id=&quot;68&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt; (&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;X&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo&gt;, &lt;/mo&gt;&lt;mtext&gt;n&lt;/mtext&gt;&lt;mo&gt;=&lt;/mo&gt;&lt;mn&gt;5&lt;/mn&gt;&lt;mn&gt;6&lt;/mn&gt;&lt;mo stretchy=&quot;false&quot;&gt;) &lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>5 <b>治疗前后两组血流变指标对比</b><mathml id="68"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>X</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>, </mo><mtext>n</mtext><mo>=</mo><mn>5</mn><mn>6</mn><mo stretchy="false">) </mo></mrow></math></mathml></a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="5">


                                    <a id="bibliography_1" title="Xu M, Yang X.Double hazards of ischemia and reperfusion arrhythmias in a patient with variant angina pectoris[J].J Electrocardiol, 2015, 48 (4) :739-743." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15121200357218&amp;v=MDQ2NjRlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFRheEE9TmlmT2ZiSzlIOVBOclk5RlorNElEbjB4b0JNVDZUNFBRSC9pclJkRw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[1]</b>
                                        Xu M, Yang X.Double hazards of ischemia and reperfusion arrhythmias in a patient with variant angina pectoris[J].J Electrocardiol, 2015, 48 (4) :739-743.
                                    </a>
                                </li>
                                <li id="7">


                                    <a id="bibliography_2" title="张倩, 许琳, 王晓骁, 等.2206例糖尿病患者临床联合使用丹红注射液的用药分析[J].中国医院药学杂志, 2017, 37 (21) :2201-2205." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGYZ201721024&amp;v=MTUxNDFIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbVZMN0tQeXJTZExHNEg5Yk9ybzlIWUlRS0Q=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[2]</b>
                                        张倩, 许琳, 王晓骁, 等.2206例糖尿病患者临床联合使用丹红注射液的用药分析[J].中国医院药学杂志, 2017, 37 (21) :2201-2205.
                                    </a>
                                </li>
                                <li id="9">


                                    <a id="bibliography_3" title="王祥荣, 邱斌, 沈继明.阿托伐他汀联合阿司匹林可有效预防2型糖尿病继发心血管疾病[J].基因组学与应用生物学, 2017, 36 (3) :1199-1203." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GXNB201703053&amp;v=MDc3MTE0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVkw3S0lqWEZiTEc0SDliTXJJOUFaNFFLREg4NHZSNFQ2ajU=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[3]</b>
                                        王祥荣, 邱斌, 沈继明.阿托伐他汀联合阿司匹林可有效预防2型糖尿病继发心血管疾病[J].基因组学与应用生物学, 2017, 36 (3) :1199-1203.
                                    </a>
                                </li>
                                <li id="11">


                                    <a id="bibliography_4" title="Kret M.Cardiac syndrome X-epidemiology, diagnostics, ethiopatoghenesis, prognosis, treatment and latest guidelines[J].Przegl Lek, 2016, 73 (1) :40-45." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Cardiac syndrome X--epidemiology,diagnostics,ethiopatoghenesis,prognosis,treatment and latest guidelines">
                                        <b>[4]</b>
                                        Kret M.Cardiac syndrome X-epidemiology, diagnostics, ethiopatoghenesis, prognosis, treatment and latest guidelines[J].Przegl Lek, 2016, 73 (1) :40-45.
                                    </a>
                                </li>
                                <li id="13">


                                    <a id="bibliography_5" title="李法权, 钟一鸣, 曾山, 等.曲美他嗪对心脏X综合征合并2型糖尿病患者冠状动脉慢血流的影响[J].临床心血管病杂志, 2016, 32 (12) :1215-1217." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=LCXB201612011&amp;v=MjgyNTN5am1WTDdLS1M3VGJMRzRIOWZOclk5RVpZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[5]</b>
                                        李法权, 钟一鸣, 曾山, 等.曲美他嗪对心脏X综合征合并2型糖尿病患者冠状动脉慢血流的影响[J].临床心血管病杂志, 2016, 32 (12) :1215-1217.
                                    </a>
                                </li>
                                <li id="15">


                                    <a id="bibliography_6" title="付东琳, 马懿, 张辉, 等.阿托伐他汀调脂治疗对冠心病合并代谢综合征患者血脂水平及心脑血管事件发生率的影响[J].中国老年学杂志, 2017, 37 (1) :70-72." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLXZ201701032&amp;v=MDY4Njg2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVkw3S1B5SFRkTEc0SDliTXJvOUdab1FLREg4NHZSNFQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[6]</b>
                                        付东琳, 马懿, 张辉, 等.阿托伐他汀调脂治疗对冠心病合并代谢综合征患者血脂水平及心脑血管事件发生率的影响[J].中国老年学杂志, 2017, 37 (1) :70-72.
                                    </a>
                                </li>
                                <li id="17">


                                    <a id="bibliography_7" >
                                        <b>[7]</b>
                                    中华医学会糖尿病学分会.中国2型糖尿病防治指南 (2013年版) [J].中华糖尿病杂志, 2014, 32 (7) :447-498.</a>
                                </li>
                                <li id="19">


                                    <a id="bibliography_8" title="中华医学会心血管病学分会, 中华心血管病杂志编辑委员会.慢性稳定型心绞痛诊断与治疗指南[J].中华心血管病杂志, 2007, 35 (3) :195-206." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZHXX200703001&amp;v=MjU1NDdmWnVabUZ5am1WTDdLUHlYVGRyRzRIdGJNckk5RlpZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3E=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[8]</b>
                                        中华医学会心血管病学分会, 中华心血管病杂志编辑委员会.慢性稳定型心绞痛诊断与治疗指南[J].中华心血管病杂志, 2007, 35 (3) :195-206.
                                    </a>
                                </li>
                                <li id="21">


                                    <a id="bibliography_9" title="徐泉崧.阿托伐他汀在老年2型糖尿病合并冠心病治疗中的效果观察[J].北方药学, 2018, 15 (2) :107-108." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=BFYX201802092&amp;v=Mjc2NDRSN3FmWnVabUZ5am1WTDdLSnl2U2RyRzRIOW5Nclk5TVpvUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1U=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[9]</b>
                                        徐泉崧.阿托伐他汀在老年2型糖尿病合并冠心病治疗中的效果观察[J].北方药学, 2018, 15 (2) :107-108.
                                    </a>
                                </li>
                                <li id="23">


                                    <a id="bibliography_10" title="张红艳.麝香保心丸联合曲美他嗪治疗糖尿病合并冠心病的疗效及对血液流变学、血脂的影响[J].中西医结合心脑血管病杂志, 2017, 15 (10) :1231-1233." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYYY201710025&amp;v=MzI2NjI4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVkw3S1B6VFNkN0c0SDliTnI0OUhZWVFLREg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[10]</b>
                                        张红艳.麝香保心丸联合曲美他嗪治疗糖尿病合并冠心病的疗效及对血液流变学、血脂的影响[J].中西医结合心脑血管病杂志, 2017, 15 (10) :1231-1233.
                                    </a>
                                </li>
                                <li id="25">


                                    <a id="bibliography_11" title="林丽, 郑方希, 刘婷婷.阿托伐他汀类药物治疗糖尿病合并冠心病效果观察[J].临床合理用药杂志, 2018, 11 (2) :84-85." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=PLHY201802055&amp;v=MzI3NTdMN0tOU0hEZDdHNEg5bk1yWTlBWVlRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbVY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                        林丽, 郑方希, 刘婷婷.阿托伐他汀类药物治疗糖尿病合并冠心病效果观察[J].临床合理用药杂志, 2018, 11 (2) :84-85.
                                    </a>
                                </li>
                                <li id="27">


                                    <a id="bibliography_12" title="周莉, 刘翠平, 武霞, 等.不同剂量阿托伐他汀对老年冠心病患者空腹血糖和糖化血红蛋白的影响[J].中国老年学杂志, 2014, 34 (4) :884-886." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLXZ201404009&amp;v=MjAwMzdMN0tQeUhUZExHNEg5WE1xNDlGYllRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbVY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[12]</b>
                                        周莉, 刘翠平, 武霞, 等.不同剂量阿托伐他汀对老年冠心病患者空腹血糖和糖化血红蛋白的影响[J].中国老年学杂志, 2014, 34 (4) :884-886.
                                    </a>
                                </li>
                                <li id="29">


                                    <a id="bibliography_13" title="李晓霞.参麦注射液联合阿托伐他汀钙片治疗冠心病慢性心力衰竭的临床疗效[J].中国临床药理学杂志, 2018, 34 (3) :221-223." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GLYZ201803009&amp;v=MTI4NTlLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVkw3S0lpSFNkTEc0SDluTXJJOUZiWVE=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[13]</b>
                                        李晓霞.参麦注射液联合阿托伐他汀钙片治疗冠心病慢性心力衰竭的临床疗效[J].中国临床药理学杂志, 2018, 34 (3) :221-223.
                                    </a>
                                </li>
                                <li id="31">


                                    <a id="bibliography_14" title="Liu Z, Chen JM, Huang H, et al.The protec-tive effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway[J].Metabolism, 2016, 65 (3) :122-130." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15122100027009&amp;v=MDg3MjNJREh3d29CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFRheEE9TmlmT2ZiSzlIOVBPcm85RlpPaw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[14]</b>
                                        Liu Z, Chen JM, Huang H, et al.The protec-tive effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway[J].Metabolism, 2016, 65 (3) :122-130.
                                    </a>
                                </li>
                                <li id="33">


                                    <a id="bibliography_15" title="许彦倩, 严炜.阿托伐他汀联合曲美他嗪对老年冠心病左心功能不全患者心功能、炎性因子和血管内皮功能的影响[J].中国老年学杂志, 2017, 37 (20) :5050-5052." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLXZ201720044&amp;v=MDk3NDFIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbVZMN0tQeUhUZExHNEg5Yk9yNDlCWUlRS0Q=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[15]</b>
                                        许彦倩, 严炜.阿托伐他汀联合曲美他嗪对老年冠心病左心功能不全患者心功能、炎性因子和血管内皮功能的影响[J].中国老年学杂志, 2017, 37 (20) :5050-5052.
                                    </a>
                                </li>
                                <li id="35">


                                    <a id="bibliography_16" title="陈泠忻, 徐勇.阿托伐他汀联合二甲双胍对血脂正常2型糖尿病患者疗效和安全性的随机对照研究[J].中国地方病防治杂志, 2017, 32 (6) :685, 687." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=DYBF201706050&amp;v=Mjc1Mjl1Wm1GeWptVkw3S0lUVEphTEc0SDliTXFZOUFaSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[16]</b>
                                        陈泠忻, 徐勇.阿托伐他汀联合二甲双胍对血脂正常2型糖尿病患者疗效和安全性的随机对照研究[J].中国地方病防治杂志, 2017, 32 (6) :685, 687.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(02),216-220 DOI:10.3969/j.issn.1008-0074.2019.02.22            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>阿托伐他汀对冠心病合并糖尿病患者的疗效及对血脂、血流变与凝血功能的影响</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E6%96%87%E9%87%91%E8%8D%A3&amp;code=25702278&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">文金荣</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E8%8C%83%E5%8D%87&amp;code=40567325&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">范升</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E4%BA%91%E5%8D%97%E7%9C%81%E7%BA%A2%E6%B2%B3%E5%B7%9E%E7%AC%AC%E4%B8%80%E4%BA%BA%E6%B0%91%E5%8C%BB%E9%99%A2%E5%BF%83%E5%86%85%E7%A7%91&amp;code=0127238&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">云南省红河州第一人民医院心内科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p><b>目的</b>:观察阿托伐他汀治疗冠心病 (CHD) 合并糖尿病患者的疗效及对患者血脂、血液流变学指标与凝血功能的影响。<b>方法</b>:选择本院2016年2月～2017年10月间收治的112例2型糖尿病 (T2DM) 合并CHD的患者纳入本次研究。患者被随机均分为常规治疗组和联合治疗组 (在常规治疗组基础上接受阿托伐他汀) , 两组均治疗3个月。观察比较两组治疗前后血糖指标、血脂、凝血功能指标、活化部分凝血活酶时间 (APTT) 、凝血酶原时间 (PT) 、组织型纤溶酶原激活剂 (t-PA) , 血流变指标:全血黏度、血浆黏度、纤维蛋白水平, 以及疗效。<b>结果</b>:联合治疗组总有效率显著高于常规治疗组 (98.21%比80.36%) , <i>P</i>=0.002。与治疗前比较, 治疗3个月后两组FPG、2hPG、HbA1c、TG、TC、LDL-C、全血黏度、血浆黏度、纤维蛋白水平显著降低, HDL-C、APTT、PT和t-PA水平显著升高 (常规治疗组HDL-C、纤维蛋白水平除外) , <i>P</i>&lt;0.05或&lt;0.01。与常规治疗组比较, 联合治疗组治疗3个月后上述血糖指标、TC、TG、LDL-C、全血黏度[ (12.19±2.67) mPa/s比 (10.15±2.18) mPa/s]、血浆黏度[ (2.31±0.29) mPa/s比 (1.78±0.23) mPa/s]和纤维蛋白[ (3.29±1.29) g/L比 (2.29±0.94) g/L]水平均降低更显著, HDL-C、APTT[ (29.98±2.92) s比 (32.07±3.24) s]、PT[ (13.89±1.63) s比 (15.14±1.75) s]、t-PA [ (394.62±12.76) U/L比 (437.56±13.54) U/L]水平升高更显著, <i>P</i>&lt;0.05或&lt;0.01。<b>结论</b>:阿托伐他汀可显著降低冠心病合并糖尿病患者的血脂水平, 改善血液变指标与凝血功能。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%86%A0%E5%BF%83%E7%97%85&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">冠心病;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E7%B3%96%E5%B0%BF%E7%97%85%2C%202%E5%9E%8B&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">糖尿病, 2型;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E9%98%BF%E6%89%98%E4%BC%90%E4%BB%96%E6%B1%80&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">阿托伐他汀;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                                            </p>
                                    <p><b>收稿日期：</b>2018-05-17</p>

            </div>
                    <h1>Therapeutic effect of atorvastatin on CHD + DM patients and its influence on blood lipids, hemorheology and coagulation</h1>
                    <h2>
                    <span>WEN Jin-rong</span>
                    <span>FAN Sheng</span>
            </h2>
                    <h2>
                    <span>Department of Cardiology, First People's Hospital of Honghezhou</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p>Objective: To observe therapeutic effect of atorvastatin on patients with coronary heart disease (CHD) complicated diabetes mellitus and its influence on blood lipids, hemorheological indexes and coagulation function. Methods:A total of 112 patients with type 2 diabetes mellitus (T2DM) complicated CHD, who were treated in our hospital from Feb 2016 to Oct 2017, were enrolled. Patients were randomly and equally divided into routine treatment group and combined treatment group (atorvastatin+ routine treatment group) , both groups were treated for three months. Levels of blood glucose, blood lipids, coagulation function indexes: activated partial thromboplastin time (APTT) , prothrombin time (PT) , tissue plasminogen activator (t-PA) , hemorheological indexes: whole blood viscosity, plasma viscosity, fibrin level and therapeutic effect were observed and compared between two groups before and after treatment. Results:Total effective rate of combined treatment group was significantly higher than that of routine treatment group (98.21% vs. 80.36%) , P=0.002. Compared with before treatment, after three-month treatment, there were significant reductions in levels of FPG, 2 hPG, HbA1 c, TG, TC, LDL-C, whole blood viscosity, plasma viscosity, fibrin, and significant rise in levels of HDL-C, APTT, PT and t-PA in two groups except HDL-C and fibrin levels of routine treatment group, P&lt;0.05 or &lt;0.01. Compared with routine treatment after three-month treatment, there were significant reductions in levels of above blood glucose indexes, TC, TG, LDL-C, whole blood viscosity [ (12.19±2.67) mPa/s vs. (10.15±2.18) mPa/s], plasma viscosity [ (2.31±0.29) mPa/s vs. (1.78±0.23) mPa/s] and fibrin [ (3.29±1.29) g/L vs. (2.29±0.94) g/L], and significant rise in levels of HDL-C, APTT[ (29.98±2.92) s vs. (32.07±3.24) s], PT[ (13.89±1.63) s vs. (15.14±1.75) s] and t-PA [ (394.62±12.76) U/L vs. (437.56±13.54) U/L] in combined treatment group, P&lt;0.05 or &lt;0.01. Conclusion:Atorvastatin can significantly reduce blood lipid levels, contribute to improving hemorheological indexes and coagulation function in CHD + DM patients.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Coronary%20disease&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Coronary disease;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Type%202%2C%20diabetes&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Type 2, diabetes;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Atorvastatin&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Atorvastatin;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                                            </p>
                                    <p><b>Received：</b> 2018-05-17</p>
                            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="37">冠心病是临床上一种十分常见的心血管系统疾病, 本病在我国的发病率呈现出显著的持续性升高趋势, 目前已经引起全社会范围内的广泛关注。2型糖尿病 (T2DM) 是临床上一种十分常见的慢性糖脂代谢紊乱性疾病, T2DM的主要病理特征表现为胰岛素抵抗与胰岛素分泌缺乏。本病可诱发心脑血管系统、肾脏、眼底以及外周血管等并发症, 并发症是导致T2DM患者致残、病死的主要原因<citation id="74" type="reference"><link href="5" rel="bibliography" /><link href="7" rel="bibliography" /><link href="9" rel="bibliography" /><sup>[<a class="sup">1</a>,<a class="sup">2</a>,<a class="sup">3</a>]</sup></citation>。冠心病患者中部分合并有T2DM, 同时冠心病也是T2DM的一种常见的危重并发症, 两种疾病互为诱因、相互促进病情进展, 互为对方的危险因素。主要是由于T2DM患者血糖水平长期偏高, 使机体长期处于微炎性状态下, 而提高内皮功能损伤的发生几率, 从而促进了动脉粥样硬化的形成。加之糖脂代谢异常而使凝血因子的活性升高, 抑制了纤溶活性, 形成血流变异常, 加重了动脉内脂质沉积与积聚, 最终导致了血栓形成及冠心病的发生<citation id="75" type="reference"><link href="11" rel="bibliography" /><link href="13" rel="bibliography" /><link href="15" rel="bibliography" /><sup>[<a class="sup">4</a>,<a class="sup">5</a>,<a class="sup">6</a>]</sup></citation>。因此, 对于冠心病合并T2DM患者的治疗应在常规治疗的基础上, 积极控制血脂水平以降低冠心病与心血管意外的发生风险。本院在常规T2DM用药的基础上联合应用阿托伐他汀进行治疗, 取得了一定成果, 报告如下。</p>
                </div>
                <h3 id="38" name="38" class="anchor-tag"><b>1 资料与方法</b></h3>
                <h4 class="anchor-tag" id="39" name="39">1.1 一般资料</h4>
                <div class="p1">
                    <p id="40">选择本院2016年2月～2017年10月间收治的112例冠心病合并T2DM患者。诊断标准:T2DM依据《中国2型糖尿病防治指南 (2013年版) 》<citation id="76" type="reference"><link href="17" rel="bibliography" /><sup>[<a class="sup">7</a>]</sup></citation>诊断, 冠心病依据《慢性稳定型心绞痛诊断与治疗指南》<citation id="77" type="reference"><link href="19" rel="bibliography" /><sup>[<a class="sup">8</a>]</sup></citation>诊断。纳入标准:①同时符合上述两项诊断标准的患者;②在了解本次研究内容的基础上自愿入组且取得知情同意文件的患者;③入组前未服用抗凝血类药物的患者;④入组时未合并高脂血症。排除标准:①合并心脏、胰脏、肺部器质性病变、先天性生理结构异常以及其他重症疾病的患者;②合并胰腺癌、肺癌等恶性肿瘤的患者;③肝、肾功能不全或重症疾病患者;④合并自身免疫系统、血液系统重症疾病, 甲状腺疾病, 免疫功能、凝血功能障碍的患者;⑤心脑血管意外急性期、感染性疾病急性期、外科手术恢复期的患者;⑥处于哺乳期、备孕、妊娠期、围绝经期等特殊生理时期的患者;⑦1型糖尿病、妊娠期糖尿病患者;⑧对于本次研究涉及药物有过敏史的患者。本次研究经本院伦理委员会批准后开展。根据抽签法结合患者主观意愿, 入选患者被均分为常规治疗组和联合治疗组, 每组各56例。常规治疗组中男27例, 女29例;年龄39～73 (58.47±8.12) 岁;病程3～6 (4.62±1.03) 年。联合治疗组中男28例, 女28例;年龄为39～75 (58.52±8.16) 岁;病程2～8 (4.68±1.05) 年。两组一般资料无统计学差异 (<i>P</i>均&gt;0.05) , 具有可比性。</p>
                </div>
                <h4 class="anchor-tag" id="41" name="41">1.2 治疗方法</h4>
                <div class="p1">
                    <p id="42">常规治疗组采取常规治疗, 包括饮食控制、适当运动、抗凝血、抗血小板等基础治疗;药物治疗包括:美托洛尔 (阿斯利康制药出品, 国药准字H32025391) 12.5mg/次, 2次/d, 口服;二甲双胍 (中美上海施贵宝制药有限公司出品, 国药准字 H20023370) 0.25g/次, 3次/d, 三餐前口服, 胃肠反应过大者于餐中或餐后口服, 如血糖控制不理想可增加用量单日最大总用量不超过2g;对于使用二甲双胍达到最大耐受量仍无法理想控制血糖水平的患者, 给予门冬胰岛素30注射液 (丹麦诺和诺德公司出品, 国药准字J20140139) 初始剂量为6单位/次, 2次/d, 于早、晚餐前注射, 根据患者情况调整用量至血糖稳定于正常范围内。联合治疗组在常规治疗组上述治疗的同时联合应用阿托伐他汀治疗, 给予阿托伐他汀 (北京嘉林药业出品, 国药准字H20093819) 20mg/d, 1次/d, 口服。两组均以3个月为1个疗程。</p>
                </div>
                <h4 class="anchor-tag" id="43" name="43">1.3 观察指标</h4>
                <div class="p1">
                    <p id="44">治疗1疗程后依据相关文献标准评估临床疗效<citation id="78" type="reference"><link href="21" rel="bibliography" /><sup>[<a class="sup">9</a>]</sup></citation>。显效:全血空腹血糖&lt;6.1mmol/L, 且餐后2h血糖&lt;10mmol/L, 心绞痛发作次数≤6次/周, 持续时间≤5min, 硝酸甘油用量≤4片, 心电图检查正常;有效:血糖水平高于显效血糖水平5%, 心绞痛发作次数≤21次/周, 持续时间≤9min, 硝酸甘油用量≤9片, 心电图检查基本正常;无效:以未达上述标准或较治疗前加重。总有效率= (显效例数+有效例数) /总例数×100%</p>
                </div>
                <div class="p1">
                    <p id="45">观察两组患者治疗前、治疗3个月后血糖指标:空腹血糖 (FPG) 、餐后2h血糖 (2hPG) 、糖化血红蛋白 (HbA1c) , 血脂指标:甘油三酯 (TG) 、总胆固醇 (TC) 、高密度脂蛋白-胆固醇 (HDL-C) 、低密度脂蛋白-胆固醇 (LDL-C) , 凝血功能指标:活化部分凝血活酶时间 (APTT) 、凝血酶原时间 (PT) 、组织型纤溶酶原激活剂 (t-PA) , 血流变指标:全血黏度、血浆黏度、纤维蛋白的变化情况。</p>
                </div>
                <h4 class="anchor-tag" id="46" name="46">1.4 统计学处理</h4>
                <div class="p1">
                    <p id="47">采用SPSS 21.0软件进行研究数据的统计学分析。计量资料以均数±标准差<mathml id="48"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>X</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml>表示, 比较采用<i>t</i>检验, 计数资料以百分率表示, 比较采用<i>χ</i><sup>2</sup>检验。<i>P</i>&lt;0.05为差异有统计学意义。</p>
                </div>
                <h3 id="49" name="49" class="anchor-tag"><b>2 结 果</b></h3>
                <h4 class="anchor-tag" id="50" name="50">2.1 临床疗效</h4>
                <div class="p1">
                    <p id="51">联合治疗组总有效率为98.21%, 显著高于常规治疗组的80.36%, <i>P</i>=0.002;见表1。</p>
                </div>
                <h4 class="anchor-tag" id="52" name="52">2.2 两组血糖水平比较</h4>
                <div class="p1">
                    <p id="53">治疗前两组FPG、2hPG、HbA1c水平均无统计学差异, <i>P</i>均&gt;0.05;治疗后两组FPG、2hPG、HbA1c水平均较治疗前显著降低, <i>P</i>均=0.001;治疗后联合治疗组患者上述指标水平均显著低于常规治疗组, <i>P</i>均=0.001;见表2。</p>
                </div>
                <div class="area_img" id="54">
                    <p class="img_tit"><b>表</b>1 <b>两组临床疗效对比</b> (n=56)  <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="54" border="1"><tr><td><br />组别</td><td>显效<br /><i>n</i> (%) </td><td>有效<br /><i>n</i> (%) </td><td>无效<br /><i>n</i> (%) </td><td>总有效率<br /><i>n</i> (%) </td></tr><tr><td><br />常规治疗组</td><td>17 (30.36) </td><td>28 (50) </td><td>11 (19.64) </td><td>45 (80.36) </td></tr><tr><td><br />联合治疗组</td><td>23 (41.07) </td><td>32 (57.14) </td><td>1 (1.79) </td><td>55 (98.21) <sup>△△</sup></td></tr><tr><td><br /><i>χ</i><sup>2</sup></td><td></td><td></td><td></td><td>9.333</td></tr><tr><td><br /><i>P</i></td><td></td><td></td><td></td><td>0.002</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:与常规治疗组比较△<i>P</i>&lt;0.05, △△<i>P</i>&lt;0.01。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <div class="area_img" id="55">
                    <p class="img_tit"><b>表</b>2 <b>治疗前后两组血糖水平对比</b><mathml id="56"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>X</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>, </mo><mtext>n</mtext><mo>=</mo><mn>5</mn><mn>6</mn><mo stretchy="false">) </mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="55" border="1"><tr><td><br />组别</td><td>空腹血糖<br /> (mmol/L) </td><td>餐后2h血糖<br /> (mmol/L) </td><td>糖化血红蛋白<br /> (%) </td></tr><tr><td><br />常规治疗组</td><td></td><td></td><td></td></tr><tr><td><br /> 治疗前</td><td>12.65±3.12</td><td>14.93±3.89</td><td>9.86±2.31</td></tr><tr><td><br /> 治疗后</td><td>8.12±1.81<sup>**</sup></td><td>11.71±2.57<sup>**</sup></td><td>7.91±1.72<sup>**</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>9.398/0.001</td><td>5.168/0.001</td><td>5.067/0.001</td></tr><tr><td><br />联合治疗组</td><td></td><td></td><td></td></tr><tr><td><br /> 治疗前</td><td>12.68±3.16</td><td>14.96±3.91</td><td>9.89±2.33</td></tr><tr><td><br /> 治疗后</td><td>6.39±1.79<sup>**△△</sup></td><td>8.12±1.62<sup>**△△</sup></td><td>6.17±1.14<sup>**△△</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>12.961/0.001</td><td>12.094/0.001</td><td>10.732/0.001</td></tr><tr><td><br />治疗前<i>t</i>/<i>P</i></td><td>0.051/0.960</td><td>0.041/0.968</td><td>0.068/0.946</td></tr><tr><td><br />治疗后<i>t</i>/<i>P</i></td><td>5.086/0.001</td><td>8.843/0.001</td><td>6.310/0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:与治疗前比较*<i>P</i>&lt;0.05, **<i>P</i>&lt;0.01。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="57" name="57">2.3 两组血脂水平比较</h4>
                <div class="p1">
                    <p id="58">治疗前两组患者各血脂水平均无统计学差异, <i>P</i>均&gt;0.05;与治疗前比较, 治疗后两组TG、TC、LDL-C水平均显著降低, 仅联合治疗组的HDL-C水平显著升高 (<i>P</i>均=0.001) ;治疗后联合治疗组TG、TC、LDL-C水平显著低于常规治疗组, HDL-C水平显著高于常规治疗组 (<i>P</i>&lt;0.05或&lt;0.01) 。见表3。</p>
                </div>
                <h4 class="anchor-tag" id="59" name="59">2.4 两组凝血功能指标比较</h4>
                <div class="p1">
                    <p id="60">治疗前两组凝血功能指标均无统计学差异, <i>P</i>均&gt;0.05;治疗后两组APTT、PT、t-PA水平均较治疗前显著延长和升高, <i>P</i>&lt;0.05或&lt;0.01;治疗后联合治疗组凝血功能指标均显著高于常规治疗组 (<i>P</i>均=0.001) 。见表4。</p>
                </div>
                <div class="area_img" id="61">
                    <p class="img_tit"><b>表</b>3 <b>治疗前后两组血脂指标对比</b><mathml id="62"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>X</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>, </mo><mtext>n</mtext><mo>=</mo><mn>5</mn><mn>6</mn><mo stretchy="false">) </mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="61" border="1"><tr><td><br />组别</td><td>时间</td><td>甘油三酯<br /> (mmol/L) </td><td>总胆固醇<br /> (mmol/L) </td><td>低密度脂蛋白-胆固醇<br /> (mmol/L) </td><td>高密度脂蛋白-胆固醇<br /> (mmol/L) </td></tr><tr><td><br />常规治疗组</td><td>治疗前</td><td>1.68±0.21</td><td>5.17±1.34</td><td>3.09±0.98</td><td>1.37±0.21</td></tr><tr><td><br /></td><td>治疗后</td><td>1.14±0.16<sup>**</sup></td><td>4.25±1.21<sup>**</sup></td><td>2.36±0.91<sup>**</sup></td><td>1.41±0.27</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>15.306/0.001</td><td>3.813/0.001</td><td>4.085/0.001</td><td>0.875/0.383</td></tr><tr><td><br />联合治疗组</td><td>治疗前</td><td>1.69±0.23</td><td>5.19±1.37</td><td>3.11±1.01</td><td>1.34±0.19</td></tr><tr><td><br /></td><td>治疗后</td><td>0.78±0.12<sup>**△△</sup></td><td>3.68±1.08<sup>**△</sup></td><td>1.98±0.82<sup>**△</sup></td><td>1.68±0.29<sup>**△△</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>26.250/0.001</td><td>6.477/0.001</td><td>6.500/0.001</td><td>7.339/0.001</td></tr><tr><td><br />治疗前<i>t</i>/<i>P</i></td><td></td><td>0.240/0.811</td><td>0.078/0.938</td><td>0.106/0.915</td><td>0.793/0.430</td></tr><tr><td><br />治疗后<i>t</i>/<i>P</i></td><td></td><td>13.470/0.001</td><td>2.630/0.010</td><td>2.321/0.022</td><td>5.099/0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <div class="area_img" id="63">
                    <p class="img_tit"><b>表</b>4 <b>治疗前后两组凝血功能指标对比</b><mathml id="64"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>X</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>, </mo><mtext>n</mtext><mo>=</mo><mn>5</mn><mn>6</mn><mo stretchy="false">) </mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="63" border="1"><tr><td><br />组别</td><td>活化部分凝血<br />活酶时间 (s) </td><td>凝血酶原时间<br /> (s) </td><td>组织纤溶酶原<br />激活剂 (U/L) </td></tr><tr><td><br />常规治疗组</td><td></td><td></td><td></td></tr><tr><td><br /> 治疗前</td><td>28.62±2.18</td><td>13.18±1.52</td><td>383.45±11.58</td></tr><tr><td><br /> 治疗后</td><td>29.98±2.92<sup>**</sup></td><td>13.89±1.63<sup>*</sup></td><td>394.62±12.76<sup>**</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>2.793/0.006</td><td>2.384/0.019</td><td>4.851/0.001</td></tr><tr><td><br />联合治疗组</td><td></td><td></td><td></td></tr><tr><td><br /> 治疗前</td><td>28.58±2.15</td><td>13.14±1.46</td><td>382.97±11.49</td></tr><tr><td><br /> 治疗后</td><td>32.07±3.24<sup>**△△</sup></td><td>15.14±1.75<sup>**△△</sup></td><td>437.56±13.54<sup>**△△</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>6.716/0.001</td><td>6.567/0.001</td><td>23.004/0.001</td></tr><tr><td><br />两组治疗前<i>t</i>/<i>P</i></td><td>0.098/0.922</td><td>0.142/0.887</td><td>0.220/0.826</td></tr><tr><td><br />两组治疗后<i>t</i>/<i>P</i></td><td>3.586/0.001</td><td>3.911/0.001</td><td>17.271/0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="65" name="65">2.5 两组血流变指标比较</h4>
                <div class="p1">
                    <p id="66">治疗前两组血液变指标无统计学差异, <i>P</i>均&gt;0.05;与治疗前比较, 治疗后两组全血黏度、血浆黏度均显著降低, 联合治疗组纤维蛋白水平显著降低 (<i>P</i>均&lt;0.01) ;治疗后联合治疗组各项血流变指标均显著低于常规治疗组 (<i>P</i>均=0.001) 。见表5。</p>
                </div>
                <div class="area_img" id="67">
                    <p class="img_tit"><b>表</b>5 <b>治疗前后两组血流变指标对比</b><mathml id="68"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>X</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>, </mo><mtext>n</mtext><mo>=</mo><mn>5</mn><mn>6</mn><mo stretchy="false">) </mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="67" border="1"><tr><td><br />组别</td><td>全血黏度<br /> (mPa/s) </td><td>血浆黏度<br /> (mPa/s) </td><td>纤维蛋白<br /> (g/L) </td></tr><tr><td><br />常规治疗组</td><td></td><td></td><td></td></tr><tr><td><br /> 治疗前</td><td>13.86±3.12</td><td>2.67±0.35</td><td>3.72±1.31</td></tr><tr><td><br /> 治疗后</td><td>12.19±2.67<sup>**</sup></td><td>2.31±0.29<sup>**</sup></td><td>3.29±1.29<sup>**</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>3.043/0.003</td><td>5.927/0.001</td><td>1.750/0.083</td></tr><tr><td><br />联合治疗组</td><td></td><td></td><td></td></tr><tr><td><br /> 治疗前</td><td>13.89±3.14</td><td>2.69±0.36</td><td>3.74±1.32</td></tr><tr><td><br /> 治疗后</td><td>10.15±2.18<sup>**△△</sup></td><td>1.78±0.23<sup>**△△</sup></td><td>2.29±0.94<sup>**△△</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>7.322/0.001</td><td>15.941/0.001</td><td>6.696/0.001</td></tr><tr><td><br />两组治疗前<i>t</i>/<i>P</i></td><td>0.051/0.960</td><td>0.298/0.766</td><td>0.080/0.936</td></tr><tr><td><br />两组治疗后<i>t</i>/<i>P</i></td><td>4.429/0.001</td><td>10.715/0.001</td><td>4.688/0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h3 id="69" name="69" class="anchor-tag"><b>3 讨 论</b></h3>
                <div class="p1">
                    <p id="70">改革开放以来, 我国人民收入水平显著提高, 饮食结构、生活习惯等均发生重大改变。在遗传、饮食结构改变、活动量改变等诸多因素共同作用下, 我国冠心病、T2DM的发病率均呈现持续上升趋势。由于冠心病、T2DM尚无彻底根治方法以及其通过诱发相关高危并发症而具有的较高致残、病死率, 目前已引起全社会范围内的广泛关注。冠心病是T2DM患者的最常见合并症, 有研究表明临床上约有80%左右的T2DM患者死于心血管疾病<citation id="79" type="reference"><link href="23" rel="bibliography" /><sup>[<a class="sup">10</a>]</sup></citation>。T2DM为冠心病的一项高危因素, 其为一种糖脂代谢紊乱综合征, 可导致患者血脂偏高或形成高脂血症, 加大了冠状动脉内脂质物质沉积、聚集的风险, 长期易形成血栓或附着于血管壁形成冠脉狭窄而发生冠心病。T2DM患者的血糖水平长期偏高, 可对内皮细胞的DNA合成产生抑制作用, 高血糖状态可导致机体长期处于微炎症状态下, 加之高血糖导致血流速减慢形成缺氧状态下自由基过度游离, 而增加冠脉血管壁内皮的损伤, 继而释放出多种活性物质, 而引起血小板活性过度激活、凝血功能与纤溶系统异常。同时还可诱发冠脉内已经形成的脂质斑块在上述诸多因素共同作用下发生破溃、脱落而阻塞冠脉, 发生急性心血管事件而危及患者生命安全。因此对于T2DM患者的治疗应在控制血糖水平的基础上, 积极控制血脂水平, 以降低心血管疾病或意外的发生风险。血糖、血脂的异常与粥样动脉硬化的形成与进展具有相互促进的作用。有研究表明高血糖、高血脂是冠心病形成与进展的危险因素<citation id="80" type="reference"><link href="25" rel="bibliography" /><link href="27" rel="bibliography" /><sup>[<a class="sup">11</a>,<a class="sup">12</a>]</sup></citation>。因此降血脂治疗具有辅助降低T2DM患者血糖水平的作用。</p>
                </div>
                <div class="p1">
                    <p id="71">他汀类药物是临床一种治疗高胆固醇类病变与动脉粥样硬化的首选药物。而阿托伐他汀是目前临床上最常用的一种他汀类药物。阿托伐他汀可经由抑制羟甲基戊二酸单酰辅酶A还原酶, 起到调节TC、TG、HDL-C的作用。阿托伐他汀同时还具有降低血压、抗氧化、免疫调节等作用, 因此可稳定动脉硬化的斑块、改善内皮细胞功能, 对于预防急性心血管事件具有积极疗效。目前阿托伐他汀在冠心病及其相关疾病的临床上得到广泛应用<citation id="82" type="reference"><link href="29" rel="bibliography" /><link href="31" rel="bibliography" /><link href="33" rel="bibliography" /><sup>[<a class="sup">13</a>,<a class="sup">14</a>,<a class="sup">15</a>]</sup></citation>。同时有研究表明, 阿托伐他汀在降低血脂方面具有较高的选择性, 应用于血脂正常的T2DM患者治疗中在辅助降低血糖水平的同时, 不会发生过度降低血脂情况, 用药安全<citation id="81" type="reference"><link href="35" rel="bibliography" /><sup>[<a class="sup">16</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="72">本次研究中, 联合治疗组在常规治疗的基础上联合应用阿托伐他汀进行治疗, 结果表明联合治疗组治疗一疗程后, 临床总有效率显著高于常规治疗组 (<i>P</i>=0.001) ;提示阿托伐他汀具有提高冠心病合并T2DM临床疗效的明确作用。同时, 两组患者通过治疗血糖水平均显著下降, 且治疗后联合治疗组患者的血糖水平显著低于常规治疗组 (<i>P</i>均=0.001) ;提示阿托伐他汀具有辅助降低T2DM患者血糖水平的功效。降低血脂水平是阿托伐他汀最主要的功效。与治疗前比较, 治疗后两组TC、TG、LDL-C水平均显著降低, 仅联合治疗组的HDL-C显著升高 (<i>P</i>均=0.001) 。由于联合治疗组患者血糖、血脂水平均得到有效改善, 从而降低了血小板活性, 使患者凝血状态得到有效缓解, 因此联合治疗组患者凝血功能指标与血流变指标均显著优于常规治疗组。提示, 以阿托伐他汀辅助治疗后, 能够通过降低血黏度、抑制高凝状态的方式加快动脉血流速, 同时以降低血脂水平为基础, 起到预防动脉粥样硬化发生或减缓动脉粥样硬化进程的作用, 从而有效缓解冠心病症状。并且由于阿托伐他汀具有抗炎、抗氧化等作用, 可有效预防已经形成的斑块发生破溃、脱落而引发心血管意外。</p>
                </div>
                <div class="p1">
                    <p id="73">综上所述, 阿托伐他汀应用于冠心病合并糖尿病的治疗中, 具有显著提高临床疗效, 辅助降低血糖、降低血脂水平、改善血流变与凝血功能的明确优势, 并且口服用药简单易行, 值得于临床治疗中推广应用。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="5">
                            <a id="bibliography_1" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15121200357218&amp;v=MDA3Nzg0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjBUYXhBPU5pZk9mYks5SDlQTnJZOUZaKzRJRG4weG9CTVQ2VA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[1]</b>Xu M, Yang X.Double hazards of ischemia and reperfusion arrhythmias in a patient with variant angina pectoris[J].J Electrocardiol, 2015, 48 (4) :739-743.
                            </a>
                        </p>
                        <p id="7">
                            <a id="bibliography_2" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGYZ201721024&amp;v=MTIzMTZZSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVkw3S1B5clNkTEc0SDliT3JvOUg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[2]</b>张倩, 许琳, 王晓骁, 等.2206例糖尿病患者临床联合使用丹红注射液的用药分析[J].中国医院药学杂志, 2017, 37 (21) :2201-2205.
                            </a>
                        </p>
                        <p id="9">
                            <a id="bibliography_3" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GXNB201703053&amp;v=MDMwMzVxcUJ0R0ZyQ1VSN3FmWnVabUZ5am1WTDdLSWpYRmJMRzRIOWJNckk5QVo0UUtESDg0dlI0VDZqNTRPM3o=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[3]</b>王祥荣, 邱斌, 沈继明.阿托伐他汀联合阿司匹林可有效预防2型糖尿病继发心血管疾病[J].基因组学与应用生物学, 2017, 36 (3) :1199-1203.
                            </a>
                        </p>
                        <p id="11">
                            <a id="bibliography_4" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Cardiac syndrome X--epidemiology,diagnostics,ethiopatoghenesis,prognosis,treatment and latest guidelines">

                                <b>[4]</b>Kret M.Cardiac syndrome X-epidemiology, diagnostics, ethiopatoghenesis, prognosis, treatment and latest guidelines[J].Przegl Lek, 2016, 73 (1) :40-45.
                            </a>
                        </p>
                        <p id="13">
                            <a id="bibliography_5" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=LCXB201612011&amp;v=MjIxOTBabUZ5am1WTDdLS1M3VGJMRzRIOWZOclk5RVpZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnU=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[5]</b>李法权, 钟一鸣, 曾山, 等.曲美他嗪对心脏X综合征合并2型糖尿病患者冠状动脉慢血流的影响[J].临床心血管病杂志, 2016, 32 (12) :1215-1217.
                            </a>
                        </p>
                        <p id="15">
                            <a id="bibliography_6" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLXZ201701032&amp;v=MDE4NDJDVVI3cWZadVptRnlqbVZMN0tQeUhUZExHNEg5Yk1ybzlHWm9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[6]</b>付东琳, 马懿, 张辉, 等.阿托伐他汀调脂治疗对冠心病合并代谢综合征患者血脂水平及心脑血管事件发生率的影响[J].中国老年学杂志, 2017, 37 (1) :70-72.
                            </a>
                        </p>
                        <p id="17">
                            <a id="bibliography_7" >
                                    <b>[7]</b>
                                中华医学会糖尿病学分会.中国2型糖尿病防治指南 (2013年版) [J].中华糖尿病杂志, 2014, 32 (7) :447-498.
                            </a>
                        </p>
                        <p id="19">
                            <a id="bibliography_8" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZHXX200703001&amp;v=MDAyODhadVptRnlqbVZMN0tQeVhUZHJHNEh0Yk1ySTlGWllRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[8]</b>中华医学会心血管病学分会, 中华心血管病杂志编辑委员会.慢性稳定型心绞痛诊断与治疗指南[J].中华心血管病杂志, 2007, 35 (3) :195-206.
                            </a>
                        </p>
                        <p id="21">
                            <a id="bibliography_9" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=BFYX201802092&amp;v=MzAxMDZxZlp1Wm1GeWptVkw3S0p5dlNkckc0SDluTXJZOU1ab1FLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[9]</b>徐泉崧.阿托伐他汀在老年2型糖尿病合并冠心病治疗中的效果观察[J].北方药学, 2018, 15 (2) :107-108.
                            </a>
                        </p>
                        <p id="23">
                            <a id="bibliography_10" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYYY201710025&amp;v=MDkwNDBGckNVUjdxZlp1Wm1GeWptVkw3S1B6VFNkN0c0SDliTnI0OUhZWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[10]</b>张红艳.麝香保心丸联合曲美他嗪治疗糖尿病合并冠心病的疗效及对血液流变学、血脂的影响[J].中西医结合心脑血管病杂志, 2017, 15 (10) :1231-1233.
                            </a>
                        </p>
                        <p id="25">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=PLHY201802055&amp;v=MDg5NDJIRGQ3RzRIOW5Nclk5QVlZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am1WTDdLTlM=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b>林丽, 郑方希, 刘婷婷.阿托伐他汀类药物治疗糖尿病合并冠心病效果观察[J].临床合理用药杂志, 2018, 11 (2) :84-85.
                            </a>
                        </p>
                        <p id="27">
                            <a id="bibliography_12" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLXZ201404009&amp;v=MTkyNjRkTEc0SDlYTXE0OUZiWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVkw3S1B5SFQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[12]</b>周莉, 刘翠平, 武霞, 等.不同剂量阿托伐他汀对老年冠心病患者空腹血糖和糖化血红蛋白的影响[J].中国老年学杂志, 2014, 34 (4) :884-886.
                            </a>
                        </p>
                        <p id="29">
                            <a id="bibliography_13" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GLYZ201803009&amp;v=MjI2NDg2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVkw3S0lpSFNkTEc0SDluTXJJOUZiWVFLREg4NHZSNFQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[13]</b>李晓霞.参麦注射液联合阿托伐他汀钙片治疗冠心病慢性心力衰竭的临床疗效[J].中国临床药理学杂志, 2018, 34 (3) :221-223.
                            </a>
                        </p>
                        <p id="31">
                            <a id="bibliography_14" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15122100027009&amp;v=Mjc0NDZxUVRNbndaZVp0RmlubFVyZklJRjBUYXhBPU5pZk9mYks5SDlQT3JvOUZaT2tJREh3d29CTVQ2VDRQUUgvaXJSZEdlcg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[14]</b>Liu Z, Chen JM, Huang H, et al.The protec-tive effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway[J].Metabolism, 2016, 65 (3) :122-130.
                            </a>
                        </p>
                        <p id="33">
                            <a id="bibliography_15" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLXZ201720044&amp;v=MjM4MDU3cWZadVptRnlqbVZMN0tQeUhUZExHNEg5Yk9yNDlCWUlRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[15]</b>许彦倩, 严炜.阿托伐他汀联合曲美他嗪对老年冠心病左心功能不全患者心功能、炎性因子和血管内皮功能的影响[J].中国老年学杂志, 2017, 37 (20) :5050-5052.
                            </a>
                        </p>
                        <p id="35">
                            <a id="bibliography_16" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=DYBF201706050&amp;v=MTU4OTBabUZ5am1WTDdLSVRUSmFMRzRIOWJNcVk5QVpJUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnU=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[16]</b>陈泠忻, 徐勇.阿托伐他汀联合二甲双胍对血脂正常2型糖尿病患者疗效和安全性的随机对照研究[J].中国地方病防治杂志, 2017, 32 (6) :685, 687.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201902022" />
        <input id="dpi" type="hidden" value="200" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201902022&amp;v=MTc2NzMzenFxQnRHRnJDVVI3cWZadVptRnlqbVZMN0tQVFhNWmJHNEg5ak1yWTlIWm9RS0RIODR2UjRUNmo1NE8=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
